Stocks in play: Intellipharmaceutics International Inc.
Announced that it entered into securities purchase agreements with certain institutional investors providing for the purchase and sale of 3,636,364 common shares at a purchase price of $1.10 U.S. per share in a registered direct offering, resulting in total gross proceeds of approximately $4 million U.S. IntelliPharmaCeutics International Inc.